five

PROP Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies

收藏
NIAID Data Ecosystem2026-05-09 收录
下载链接:
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001297.v1.p1
下载链接
链接失效反馈
官方服务:
资源简介:
Approximately 550,000 babies born prematurely each year in the United States suffer from birth at a time in development when the respiratory tract and immune system would normally be protected and maintained in a naïve state. This project is a component of the NIH Prematurity and Respiratory Outcomes Program (PROP) whose goals are the identification of disease mechanisms and biomarkers to stratify premature infants, at the time of discharge, for their risk of subsequent pulmonary morbidity. This Clinical Research Center (CRC) project will investigate prematurity-dependent alterations in cellular innate and adaptive immune systems resulting in increased susceptibility to respiratory infections and environmental irritants, and leading to respiratory morbidity in the first year of life. Prior studies have established developmental (maturity) and disease-related changes in circulating and pulmonary lymphocyte populations, but a comprehensive assessment of their relationship to disease risk/outcome has not been undertaken. We hypothesize that cellular and molecular immuno-maturity is altered due to intrinsic and extrinsic factors presented by premature birth in such a way as to reduce resistance to viral infections and to promote cytotoxic damage to the lung. We will evaluate immunologic maturity by comprehensively phenotyping lymphocyte populations in peripheral blood sampled at premature delivery, at the time of discharge from the hospital and at twelve months corrected age. The lymphocytic phenotype will be analyzed particularly in the context of gestational age and maternal-fetal stressors capable of modulating oxidative stress (oxygen exposure, infection and environmental tobacco smoke exposure). Additionally, we will assess changes in the molecular phenotype of isolated CD8 lymphocytes, a cell type preferentially recruited to the lungs of premature infants and capable of contributing to disease pathogenesis, by genome-wide expression profiling, in order to uncover novel disease pathways and define a gene expression signature associated with disease risk. We propose to build a statistical model, using cellular and molecular phenotypes and additional clinical variables, for stratifying risk of lung morbidity within the first year of life. Finally, we will assess the development of the gut microbiome in the preterm subjects to correlate with the observation of development of the adaptive immune system.]]> 1.1 Inclusion Criteria: Premature infants born at gestational age 24 0/7 to 35 6/7 week and admitted to the Neonatal Intensive Care Unit or normal newborn nursery at URMC or UB. Note: At UR babies less than 24 0/7 weeks GA at birth will be enrolled in the first bracket. However, because so few of them are born at this center there will be no identified number as our goal to enroll. The lower age limit for enrollment will be 23 0/7 weeks GA at birth. Healthy term infants 37 0/7 to 41 6/7 recruited from the birthing centers or Ob/Gyn floors (3-1200 at URMC) prior to discharges Infants who are less than or equal to 7 days old 1.2 Exclusion Criteria: Infants who meet any of the following conditions will be excluded from the PROP cohort: The infant is not considered to be viable (decision made by clinical care team to not provide life-saving therapies) Congenital heart disease (not including PDA and hemodynamically insignificant VSD or ASD) Structural abnormalities of the upper airway, lungs or chest wall Other congenital malformations or syndromes that adversely affect life expectancy or cardio-pulmonary development Family is unlikely to be available for long-term follow-up as determined by the site investigators dependent on the distance of the infant's residence from the follow-up center and/or family plans to move out of the region Family does not speak or understand English ]]> Enrollment: 277 Study Start Date: August 2011 Study Completion Date: March 2016 Primary Completion Date: April 2015 (Final data collection date for primary outcome measure) ]]>
创建时间:
2017-03-06
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作